Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin.
Emovon
Osemwegie E
OE
Department of Surgery, Medical University of South Carolina, Charleston, SC, USA. emovonoe@musc.edu
Lin
Angello
A
Howell
David N
DN
Afzal
Fuad
F
Baillie
Mark
M
Rogers
Jeffrey
J
Baliga
Prabhakar K
PK
Chavin
Kenneth
K
Nickeleit
Volker
V
Rajagapalan
P R
PR
Self
Sally
S
D000258:Adenovirus Infections, Human / Q000188:drug therapy* / Q000209:etiology; D000998:Antiviral Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D016030:Kidney Transplantation / Q000276:immunology*; D008875:Middle Aged; D016035:Pancreas Transplantation / Q000276:immunology*; D012254:Ribavirin / Q000008:administration & dosage*
D000998:Antiviral Agents; D016756:Immunoglobulins, Intravenous; D012254:Ribavirin